Related Experiment Video
Updated: May 21, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Genetic changes in squamous cell lung cancer: a review
Rebecca S Heist1, Lecia V Sequist, Jeffrey A Engelman
1Department of Hematology Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA. rheist@partners.org
Targeting specific mutations in lung cancer has improved treatments, but squamous cell carcinomas remain under-addressed. This review details molecular alterations in squamous cell lung cancer to guide future therapy development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Somatic mutations in epidermal growth factor receptor and anaplastic lymphoma kinase have led to targeted therapies for non-small-cell lung cancer (NSCLC).
- Current targeted therapies are more effective in lung adenocarcinoma than squamous cell carcinoma (SCC) and in light smokers versus heavy smokers.
- Advancing NSCLC treatment requires identifying and targeting molecular alterations across all lung cancer subtypes.
Purpose of the Study:
- To review current knowledge of molecular alterations in lung squamous cell carcinoma (LSCC).
- To discuss comprehensive genomic assessment efforts in LSCC.
- To highlight specific genes driving LSCC and potential therapeutic targets.
Main Methods:
- Review of existing literature on molecular alterations in lung squamous cell carcinoma.
- Analysis of ongoing comprehensive genomic profiling studies.
- Discussion of gene-specific evidence in LSCC pathogenesis.
Main Results:
- The landscape of somatic alterations in LSCC is complex and distinct from adenocarcinoma.
- Several specific genes have been identified as potential drivers of LSCC.
- Understanding these targets is crucial for developing effective therapies.
Conclusions:
- Targeting molecular alterations in LSCC is essential for improving patient outcomes.
- Further research into LSCC genomics will uncover new therapeutic strategies.
- Comprehensive genomic analysis is key to advancing precision medicine in LSCC.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

